Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultrazonix was an Israeli medical device company that developed an innovative, non-invasive system for treating spinal conditions, specifically herniated discs. The company's flagship technology combined real-time ultrasound imaging with laser therapy to perform percutaneous laser disc decompression (PLDD). This approach allowed for high-precision targeting of the affected disc area, aiming to reduce intradiscal pressure and alleviate pain without the need for traditional open surgery. The Ultrazonix system was designed as an outpatient procedure, offering patients a faster recovery time and a lower risk profile compared to conventional surgical interventions. Although the system received regulatory clearance in several markets, the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultrazonix.